Propranolol Hydrochloride
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Change to read:
Propranolol Hydrochloride contains NLT 98.0% and NMT ▲102.0%▲ (USP 1-May-2020) of propranolol hydrochloride (C₁₆H₂₁NO₂ · HCl), calculated on the dried basis.
2 IDENTIFICATION
Change to read:
A. ▲Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197M▲ (CN 1-May-2020)
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
C. Identification Tests—General 〈191〉, Chemical Identification Tests, Chloride: Meets the requirements
3 ASSAY
Change to read:
Procedure
▲Mobile phase: Mix 1.6 g of sodium dodecyl sulfate and 0.31 g of tetrabutylammonium phosphate in a mixture of 1 mL of sulfuric acid, 450 mL of water, and 550 mL of acetonitrile. Adjust with 2 N sodium hydroxide solution to a pH of 3.3.
Standard solution: 0.2 mg/mL of USP Propranolol Hydrochloride RS in Mobile phase. Sonication may be needed to aid dissolution.
Sample solution: 0.2 mg/mL of Propranolol Hydrochloride in Mobile phase. Sonication may be needed to aid dissolution.▲
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 292 nm
Column: 4.6-mm × 25-cm; 5-µm packing L1
Flow rate: 1.8 mL/min
Injection volume: 20 µL
Run time: NLT 7 times the retention time of propranolol
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2.0
Relative standard deviation: NMT 0.73%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of propranolol hydrochloride (C₁₆H₂₁NO₂ · HCl) in the portion of Propranolol Hydrochloride taken:
Result = (rᵤ / rₛ) × (Cₛ / Cᵤ) × 100
rᵤ = peak response of propranolol from the Sample solution
rₛ = peak response of propranolol from the Standard solution
Cₛ = concentration of USP Propranolol Hydrochloride RS in the Standard solution (mg/mL)
Cᵤ = concentration of Propranolol Hydrochloride in the Sample solution (mg/mL)
▲ (USP 1-May-2020)
Acceptance criteria: 98.0%–▲102.0%▲ (USP 1-May-2020) on the dried basis
4 IMPURITIES
Residue on Ignition 〈281〉: NMT 0.1%
Change to read:
▲Organic Impurities
Mobile phase and Chromatographic system: Proceed as directed in the Assay.
System suitability solution:
0.002 mg/mL of USP Propranolol Related Compound A RS and
2 mg/mL of USP Propranolol Hydrochloride RS
in Mobile phase
Standard solution:
0.002 mg/mL of USP Propranolol Hydrochloride RS in Mobile phase
Sensitivity solution:
0.001 mg/mL of USP Propranolol Hydrochloride RS in Mobile phase from Standard solution
Sample solution:
2 mg/mL of Propranolol Hydrochloride in Mobile phase. Sonication may be needed to aid dissolution.
System suitability
Samples: System suitability solution, Standard solution, and Sensitivity solution
[Note—The relative retention times for the impurities are listed in Table 1.]
Suitability requirements
Resolution: NLT 3.0 between propranolol and propranolol related compound A, System suitability solution
Relative standard deviation: NMT ▲5.0%,▲ (ERR 1-May-2020) Standard solution
Signal-to-noise ratio: NLT 10, Sensitivity solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of each specified and unspecified impurity in the portion of Propranolol Hydrochloride taken:
Result = (rᵤ / rₛ) × (Cₛ / Cᵤ) × (1/F) × 100
rᵤ = peak response of each specified and unspecified impurity from the Sample solution
rₛ = peak response of propranolol from the Standard solution
Cₛ = concentration of USP Propranolol Hydrochloride RS in the Standard solution (mg/mL)
Cᵤ = concentration of Propranolol Hydrochloride in the Sample solution (mg/mL)
F = relative response factor (see Table 1)
Acceptance criteria: See Table 1. The reporting threshold is 0.05%.
| Name | Relative Retention Time | Relative Response Factor | Acceptance Criteria, NMT (%) |
|---|---|---|---|
| Propranolol related compound A | 0.6 | 1.4 | 0.1 |
| Propranolol | 1.0 | 1.0 | — |
| Propranolol dimerᵃ | 4.8 | 1.3 | 0.1 |
| Dinaphthyl glycerolᵇ | 5.7 | 1.9 | 0.1 |
| Any unspecified impurity | — | 1.0 | 0.10 |
| Total impurities | — | — | 0.4 |
a 3,3′-(Isopropylazanediyl)bis[1-(naphthalen-1-yloxy)propan-2-ol].
b 1,3-Bis(naphthalen-1-yloxy)propan-2-ol.
▲ (USP 1-May-2020)
5 SPECIFIC TESTS
Delete the following:
▲Melting Range or Temperature, Class Ia 〈741〉: 162°–165°▲ (USP 1-May-2020)
Delete the following:
▲Optical Rotation 〈781S〉, Specific Rotation
Sample solution: 40 mg/mL in water
Acceptance criteria: −1.0° to +1.0°▲ (USP 1-May-2020)
Loss on Drying 〈731〉
Analysis: Dry at 105° for 4 h.
Acceptance criteria: NMT 0.5%
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in well-closed containers. Store at controlled room temperature.
Change to read:
USP Reference Standards 〈11〉
USP Propranolol Hydrochloride RS
▲USP Propranolol Related Compound A RS
3-(Naphthalen-1-yloxy)propane-1,2-diol.
C₁₃H₁₄O₃ 218.25▲ (USP 1-May-2020)

